Predictive Oncology Price to Free Cash Flow Ratio 2010-2024 | POAI
Historical price to free cash flow ratio values for Predictive Oncology (POAI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-11-19 | 0.64 | 0.00 | |
| 2024-09-30 | 0.79 | $-2.49 | 0.00 |
| 2024-06-30 | 1.04 | $-2.96 | 0.00 |
| 2024-03-31 | 2.55 | $-3.33 | 0.00 |
| 2023-12-31 | 3.29 | $-3.35 | 0.00 |
| 2023-09-30 | 3.20 | $-3.30 | 0.00 |
| 2023-06-30 | 4.86 | $-3.44 | 0.00 |
| 2023-03-31 | 6.54 | $-3.39 | 0.00 |
| 2022-12-31 | 6.13 | $-3.47 | 0.00 |
| 2022-09-30 | 7.20 | $-4.40 | 0.00 |
| 2022-06-30 | 8.20 | $-4.26 | 0.00 |
| 2022-03-31 | 19.54 | $-3.70 | 0.00 |
| 2021-12-31 | 19.04 | $-4.78 | 0.00 |
| 2021-09-30 | 26.60 | $-10.28 | 0.00 |
| 2021-06-30 | 26.20 | $-9.68 | 0.00 |
| 2021-03-31 | 24.20 | $-10.51 | 0.00 |
| 2020-12-31 | 14.65 | $-20.69 | 0.00 |
| 2020-09-30 | 16.28 | $-36.38 | 0.00 |
| 2020-06-30 | 32.80 | $-60.82 | 0.00 |
| 2020-03-31 | 31.51 | $-47.07 | 0.00 |
| 2019-12-31 | 52.20 | $-60.89 | 0.00 |
| 2019-09-30 | 101.00 | $-59.05 | 0.00 |
| 2019-06-30 | 149.50 | $-44.25 | 0.00 |
| 2019-03-31 | 150.00 | $-81.00 | 0.00 |
| 2018-12-31 | 123.82 | $-85.29 | 0.00 |
| 2018-09-30 | 212.00 | $-103.52 | 0.00 |
| 2018-06-30 | 226.00 | $-127.70 | 0.00 |
| 2018-03-31 | 220.00 | $-135.26 | 0.00 |
| 2017-12-31 | 202.00 | $-141.60 | 0.00 |
| 2017-09-30 | 290.72 | $-190.13 | 0.00 |
| 2017-06-30 | 294.00 | $-173.11 | 0.00 |
| 2017-03-31 | 420.00 | $94.03 | 4.47 |
| 2016-12-31 | 560.00 | $-312.73 | 0.00 |
| 2016-09-30 | 825.00 | $-243.74 | 0.00 |
| 2016-06-30 | 762.50 | $-256.59 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| Enovis (ENOV) | United States | $2.529B | 17.15 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |